The DCE parameters including Ktrans and Ve have been used to assess glioblastoma treatment responses reflecting tumor cellularity and tumor vasculature. We hypothesized that the enhancement pattern of the ionic macrocyclic contrast agent used in glioblastoma DCE study, which interacts with the negative charge on the surface of the tumor cell, was different from that of the nonionic one. We demonstrated it with prospective DCE experiments using the orthotopic glioblastoma models as well as Ktrans and Ve from ionic were more correlated with tumor pathology than nonionic. These findings may aid clinical choice of GBCA in DCE-MRI study.
This abstract and the presentation materials are available to members only; a login is required.